To the Editor, We read with interest the findings from the FIND Trial by Rikkonen et al. regarding the efficacy of high-dose vitamin D3 supplementation for fall prevention. We commend the authors for the study's robust sample size and exceptional 5-year duration, which fill a critical evidence gap [1]. While the null findings provide important epidemiological data, specific methodological and translational nuances warrant closer scrutiny to optimize clinical interpretation.
